Search results
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Finance UK· 3 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
Bloomberg· 3 days agoPrivate equity firms Bain Capital and Cinven are exploring a potential joint bid for French...
Sanofi eyes German insulin investment of up to $1.6 billion, source says
Reuters via Yahoo Finance UK· 6 days agoFrench drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros...
French State Investment Firm Eyes Stake in Sanofi Consumer Unit
Bloomberg· 3 days agoBpifrance SACA is looking at a potential investment in Sanofi SA’s consumer health unit as it eyes...
Bpifrance eyes investment in Sanofi's consumer health business
Reuters· 2 days ago, opens new tab consumer health unit, Bloomberg News reported on Thursday. The French public investment bank is in talks with "many funds" and may team up with the winning bidder for
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 1 day agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Sanofi eyes German insulin investment of up to $1.6 bln, source says
Reuters· 5 days agoGerman newspaper Handelsblatt, which first reported the investment plan on Monday, cited German...
Sanofi CEO on AI's Impact, Lung Disease Drug Clearance
Bloomberg· 3 days agoSanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in...
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
Insider Monkey via Yahoo Finance UK· 6 days agoWe recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024...
Liposomal Doxorubicin Market is anticipated to reach USD 2,367.5 Million, growing at a 6.3% CAGR By
PharmiWeb· 2 days agoThe fight against cancer is bolstered by a growing Liposomal Doxorubicin Market, a powerful chemotherapy drug. The anticipated growth in the sales of liposomal doxorubicin is influenced by pivotal ...